Consumers currently spend 23 cents of every health care dollar on prescription drugs – an amount that can and must come down, as needlessly high drug prices and out-of-pocket spending threaten the financial security, health and well-being of American patients and their families, as well as strain Federal and State budgets.1 As such, CSRxP welcomes HHS’s Prescription Drug Pricing Blueprint as a good first step in finding ways to improve prescription drug affordability for consumers while also promoting innovation in drug development.